19 results on '"Thavaraj, Selvam"'
Search Results
2. Clinical outcomes in relapsed oropharyngeal cancer after definitive (chemo) radiotherapy.
- Author
-
De Felice, Francesca, Bird, Thomas, Michaelidou, Andriana, Jeannon, Jean‐Pierre, Simo, Ricard, Oakley, Richard, Lyons, Andrew, Fry, Alastair, Cascarini, Luke, Asit, Arora, Thavaraj, Selvam, Reis Ferreira, Miguel, Petkar, Imran, Kong, Anthony, Lei, Mary, and Guerrero Urbano, Teresa
- Subjects
OROPHARYNGEAL cancer ,CANCER relapse ,CHEMORADIOTHERAPY ,TREATMENT effectiveness ,CANCER patients ,SURVIVAL analysis (Biometry) ,PAPILLOMAVIRUS diseases ,DESCRIPTIVE statistics ,SQUAMOUS cell carcinoma ,EVALUATION - Abstract
Objectives: To report clinical outcomes of relapsed oropharyngeal squamous cell carcinoma (OPSCC) after definitive intensity‐modulated (chemo)radiotherapy [(C)RT]. Materials and methods: Data for all relapsed patients treated for OPSCC with definitive (C)RT between 2010 and 2016 were collected. Primary end‐point was post‐failure survival (PFS). Results: Overall, 273 OPSCC patients completed definitive (C)RT. Of these, 42 cases (n = 26 human papilloma virus (HPV)‐negative; n = 16 HPV‐positive) had relapsed (n = 23 persistent disease; n = 19 recurrent disease) and were included in the final analysis. Two‐year PFS for the entire population was 30.6%; 20.5% for HPV‐negative and 43.8% for HPV‐positive patients. Salvage curative surgery was associated with a significantly higher 2 years PFS rate (56.2%) compared with palliative treatment (22.9%) and best supportive care (0%) (p < 0.001). A positive trend in 2 years PFS was recorded in the early complete response cases (49.5%) versus patients who did not achieve a complete response within 3 months of the end of (C)RT (23.0%) (p = 0.11). Conclusion: A higher PFS rate is achieved when relapsed OPSCC cases are treated with salvage curative intent. HPV‐positive disease and early complete response within 3 months from the end of (C)RT may be related to better PFS. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
3. Clinico-pathological features of oropharyngeal squamous cell carcinomas in Malaysia with reference to HPV infection
- Author
-
Yap, Lee Fah, Lai, Sook Ling, Rhodes, Anthony, Sathasivam, Hans Prakash, Abdullah, Maizaton Atmadini, Pua, Kin-Choo, Rajadurai, Pathmanathan, Cheah, Phaik-Leng, Thavaraj, Selvam, Robinson, Max, and Paterson, Ian C.
- Published
- 2018
- Full Text
- View/download PDF
4. HPV Specific Testing: A Requirement for Oropharyngeal Squamous Cell Carcinoma Patients
- Author
-
Robinson, Max, Schache, Andrew, Sloan, Philip, and Thavaraj, Selvam
- Published
- 2012
- Full Text
- View/download PDF
5. Carcinoma Cuniculatum Arising in the Tongue
- Author
-
Thavaraj, Selvam, Cobb, Alistair, Kalavrezos, Nicholas, Beale, Timothy, Walker, Donald Murray, and Jay, Amrita
- Published
- 2012
- Full Text
- View/download PDF
6. Centralised pathology service for sentinel node biopsy in oral cavity cancer: The Southeast England Consortium experience.
- Author
-
Patel, Helina N., Bowe, Conor, Garg, Montey, Tighe, David, Gulati, Aakshay, Norris, Paul, Kerawala, Cyrus, McGurk, Mark, Bisase, Brian, Thavaraj, Selvam, and Schilling, Clare
- Subjects
SENTINEL lymph node biopsy ,ORAL cancer ,SQUAMOUS cell carcinoma ,PATHOLOGY ,SURVIVAL analysis (Biometry) - Abstract
Background: Sentinel lymph node biopsy is an increasingly recognised option for accurate staging and subsequent management of the clinically negative neck in early stage oral cavity squamous cell carcinoma. However, the technique is currently underused due to several logistic constraints including increased burden on pathology services. Here, we describe the feasibility of an outsourced centralised pathology processing and reporting service for sentinel lymph node biopsies in oral cavity squamous cell carcinoma. Patients and methods: The Southeast England Consortium comprises four surgical centres utilising a central pathology service. Consecutive cases between January 2016 and February 2020 were retrospectively evaluated for survival outcomes and laboratory turnaround times. Results: Twenty‐eight per cent from a cohort of 139 patients had positive sentinel nodes. There was a trend towards greater overall, disease‐free and disease‐specific survival (OS, DFS and DSS, respectively) in sentinel node negative compared to sentinel node positive patients, but these differences were not statistically significant. The sensitivity, negative predictive value and false negative rate were 92.8%, 97.0% and 6.8%, respectively. The mean and mode laboratory TAT were 5 and 4 working days, respectively. Conclusion: An outsourced centralised pathology service is a feasible option to widen the availability of sentinel node biopsy in oral cavity squamous cell carcinoma. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
7. Serial step sections at narrow intervals with immunohistochemistry are required for accurate histological assessment of sentinel lymph node biopsy in oral squamous cell carcinoma.
- Author
-
King, Claire, Elsherif, Nusaybah, Kirwan, Ruaidhrí, Schilling, Clare, Hall, Gillian, Morgan, Peter, Collins, Lisette, Sandison, Ann, Odell, Edward, and Thavaraj, Selvam
- Subjects
SENTINEL lymph node biopsy ,SQUAMOUS cell carcinoma ,SENTINEL lymph nodes ,METASTASIS ,IMMUNOHISTOCHEMISTRY - Abstract
Background: Sentinel lymph node (SLN) biopsy is an accurate staging modality in early oral squamous cell carcinoma (OSCC), but its accuracy relies on labor‐intensive histopathology protocols. We sought to determine whether serial step sections with immunohistochemistry (SSSIHC) at narrow intervals of the entire SLN are required to accurately exclude metastasis. Methods: Consecutive SLN biopsies over a 13‐year period were retrospectively evaluated. If the index section was negative for carcinoma, the entire SLN was subjected to SSSIHC at 150 μm intervals. The first section level and total number of section levels to contain carcinoma were recorded. Results: One hundred and eighteen SLN+ from 90 patients were included. SSSIHC upstaged the nodal status in 19.5% of patients. Metastasis was identified in 16.7% and 10.2% beyond section levels 4 and 6, respectively. Among SLNs requiring SSSIHC, 47.5% contained carcinoma in a single section level. Conclusion: SSSIHC of the entire SLN at 150 μm intervals are required to identify occult metastasis in OSCC. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
8. RNA in situ hybridization for human papillomavirus testing in oropharyngeal squamous cell carcinoma on a routine clinical diagnostic platform.
- Author
-
Henley‐Smith, Rhonda, Santambrogio, Alice, Andoniadou, Cynthia L., Odell, Edward, and Thavaraj, Selvam
- Subjects
IN situ hybridization ,RNA ,PAPILLOMAVIRUS disease diagnosis ,OROPHARYNGEAL cancer ,SQUAMOUS cell carcinoma - Abstract
Background: The current diagnostic standard for detection of high‐risk human papillomavirus (HPV) in oropharyngeal squamous cell carcinoma is via a two‐stage algorithm, namely p16 immunohistochemistry followed by HPV DNA in situ hybridization in p16 positive cases. This study evaluated the feasibility of automated RNA in situ hybridization on a clinical platform as a single‐step alternative to the two‐stage algorithm within a routine diagnostic histopathology setting. Methods: Thirty‐eight cases positive for both p16 and DNA in situ hybridization, 42 p16 negative cases and 20 cases positive for p16 but negative for DNA in situ hybridization were randomly selected. High‐risk HPV RNA in situ hybridization was undertaken on all cases on an automated clinical platform. Manufacturer‐recommended and on‐slide additional p16/HPV positive and negative controls were used. Test quality assurance and diagnostic RNA in situ hybridization were independently assessed by two observers. A consensus diagnosis was reached in the presence of a third observer on discordant cases. All RNA in situ hybridization results were then correlated against p16 and DNA ISH status. Results: Inter‐slide RNA in situ hybridization staining variation was observed in control sections. RNA in situ hybridization demonstrated a high inter‐observer agreement rate (κ =.897, P <.001). Following consensus review, there was full concordance between RNA in situ hybridization and the current standard. Conclusion: Human papillomavirus testing by standalone automated RNA in situ hybridization on a clinical diagnostic platform currently available in routine diagnostic histopathology laboratories is a feasible alternative to the two‐step algorithm of p16 and DNA in situ hybridization. Control tissue staining procedures need to be adapted to achieve the most accurate results. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
9. Trans-oral robotic surgery for oropharyngeal cancer: implications for pathologists.
- Author
-
Robinson, Max, O'Hara, James, Siddiq, Somiah, Jones, Terry M., Paleri, Vinidh, Sandison, Ann, and Thavaraj, Selvam
- Abstract
Trans-oral robotic surgery (TORS) was approved by the FDA in 2009 and over the past decade head and neck surgeons have adopted the technology for the benefit of their patients. Whilst the surgical methods have evolved, there has been little consideration about the pathological assessment of the specimens and a lack of understanding around the oncological principles that underpin minimally invasive surgical techniques in the head and neck region. This article will highlight the issues encountered during the reporting of TORS specimens. The challenges include identifying anatomical boundaries, block selection, assessment of resection margins, the use of intra-operative frozen sections, the assessment of tongue base mucosectomies for patients with head and neck cancer of unknown primary, and TORS for recurrent disease. The article will conclude with emerging innovations, including i-Knife, narrow band imaging and the potential of step serial sections to identify sub-clinical HPV-related oropharyngeal squamous cell carcinomas. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
10. Clinical evaluation of tumour‐infiltrating lymphocytes as a prognostic factor in patients with human papillomavirus‐associated oropharyngeal squamous cell carcinoma.
- Author
-
Ruangritchankul, Komkrit, Sandison, Ann, Warburton, Fiona, Guerrero‐Urbano, Teresa, Reis Ferreira, Miguel, Lei, Mary, and Thavaraj, Selvam
- Subjects
LYMPHOKINES ,LYMPHOCYTE count ,SQUAMOUS cell carcinoma ,PROGRESSION-free survival - Abstract
Clinical evaluation of tumour‐infiltrating lymphocytes as a prognostic factor in patients with human papillomavirus‐associated oropharyngeal squamous cell carcinoma Aims: The majority of patients with human papillomavirus (HPV)‐associated oropharyngeal squamous cell carcinoma (OpSCC) have favourable survival outcomes, but a significant minority of individuals will die of their disease. There are currently no definitive criteria with which to identify HPV‐associated OpSCC patients with poor outcomes. Recent reports suggest that quantitative evaluation of T‐cell subpopulations in OpSCC may be of prognostic value, but the methods used have limited utility in a clinical diagnostic setting. We therefore sought to determine the clinical prognostic utility of tumour‐infiltrating lymphocyte (TIL) evaluation in patients with HPV‐associated OpSCC within the context of a diagnostic histopathology setting. Methods and results: Representative diagnostic haematoxylin and eosin (H&E)‐stained slides from 232 consecutive HPV‐associated OpSCC patients were classified as containing a high (TILHi; diffuse, lymphocytes in >80% of tumour and stroma), moderate (TILMod; patchy, present in 20–80% of tumour and stroma) or low (TILLo; sparse or absent, present in <20% of tumour and stroma) TILs. Interobserver reliability was assessed, and TIL category was then correlated with overall survival (OS) and disease‐free survival (DFS). Univariate and multivariate analyses showed statistically significant differences in OS and DFS estimates when TILHi and TILMod patients were compared with TILLo patients (P < 0.0001 for TILHi versus TILLo; P < 0.0001 for TILMod versus TILLo). Statistical significance was retained when TILHi and TILMod patients were grouped into a single category (TILHi) and compared with TILLo patients (P < 0.0001). Conclusion: We demonstrate the prognostic utility of TILs in patients with HPV‐associated OpSCC in clinical practice. A binary system classifying HPV‐associated OpSCC into TILHi and TILLo on the basis of routine H&E staining stratifies patients into those with potentially favourable and unfavourable survival outcomes, respectively. [ABSTRACT FROM AUTHOR]
- Published
- 2019
- Full Text
- View/download PDF
11. F-FDG PET/CT to assess response and guide risk-stratified follow-up after chemoradiotherapy for oropharyngeal squamous cell carcinoma.
- Author
-
Bird, Thomas, Barrington, Sally, Thavaraj, Selvam, Jeannon, Jean-Pierre, Lyons, Andrew, Oakley, Richard, Simo, Ricard, Lei, Mary, and Guerrero Urbano, Teresa
- Subjects
SQUAMOUS cell carcinoma ,PHARYNGEAL cancer ,POSITRON emission tomography ,FLUORODEOXYGLUCOSE F18 ,CHEMORADIOTHERAPY ,DIAGNOSIS - Abstract
Purpose: To evaluate the use of F-FDG PET/CT as the principal investigation to assess tumour response, to determine the need for further surgery and to guide follow-up following radical chemoradiotherapy for stage III/IV oropharyngeal squamous cell carcinoma (OPSCC). Methods: A retrospective analysis was undertaken in 146 patients treated at our centre with radical chemoradiotherapy for OPSCC and who had a PET/CT scan to assess response. According to the PET/CT findings, patients were divided into four groups and recommendations: (1) complete metabolic response (enter clinical follow-up); (2) low-level uptake only (follow-up PET/CT scan in 12 weeks); (3) residual uptake suspicious for residual disease (further investigation with or without neck dissection); and (4) new diagnosis of distant metastatic disease (palliative treatment options). Results: The initial PET/CT scan was performed at a median of 12.4 weeks (range 4.3 - 21.7 weeks) following treatment. Overall sensitivity and specificity rates were 92.0 % (74.0 - 99.0 %) and 85 % (77.5 - 90.9 %). Of the 146 patients, 90 (62 %) had a complete response and had estimated 3-year overall and disease-free survival rates of 91.9 % (85.6 - 98.2 %) and 85.6 % (78.0 - 93.2 %), respectively, 17 (12 %) had residual low-level uptake only (with two having confirmed residual disease on subsequent PET/CT, both surgically salvaged), 30 (21 %) had suspicious residual uptake (12 proceeded to neck dissection; true positive rate at surgery 33 %). HPV-positive patients with reassuring PET/CT findings had an estimated 3-year progression-free survival rate of 91.7 % (85.2 - 98.2 %), compared with 66.2 % (41.5 - 90.9 %) of HPV-negative patients. Conclusion: A strategy of using PET/CT results alongside clinical examination to help select patients for salvage surgery appears successful. Despite a complete response on the 12-week PET/CT scan, HPV-negative patients have a significant risk of disease relapse in the following 2 years and further studies to assess whether surveillance imaging in this group could improve outcomes are warranted. [ABSTRACT FROM AUTHOR]
- Published
- 2016
- Full Text
- View/download PDF
12. Biphenotypic human papillomavirusassociated head and neck squamous cell carcinoma: a report of two cases.
- Author
-
Pitiyage, Gayani, Lei, Mary, Urbano, Teresa Guererro, Odell, Edward, and Thavaraj, Selvam
- Subjects
PAPILLOMAVIRUSES ,SQUAMOUS cell carcinoma ,KERATINIZATION ,HEAD & neck cancer ,HUMAN phenotype - Abstract
Human papillomavirus-associated oropharyngeal squamous cell carcinoma is now recognised as a subtype of head and neck cancer with distinct clinical, molecular and histological characteristics. The majority of these carcinomas are of non-keratinising squamous type but there is a growing number of histomorphologic variants of this disease. Here we describe the clinical, histomorphologic and immunophenotypic features of two cases of human papillomavirus-associated oropharyngeal squamous cell carcinoma demonstrating a clearly delineated biphasic differentiated and undifferentiated phenotype. [ABSTRACT FROM AUTHOR]
- Published
- 2015
- Full Text
- View/download PDF
13. Patients with HPV-related tonsil squamous cell carcinoma rarely harbour oncogenic HPV infection at other pharyngeal sites.
- Author
-
Thavaraj, Selvam, Stokes, Angela, Mazuno, Kazuya, Henley-Smith, Rhonda, Suh, Yae-eun, Paleri, Vinidh, Tavassoli, Mahvash, Odell, Edward, and Robinson, Max
- Subjects
- *
OROPHARYNGEAL cancer , *SQUAMOUS cell carcinoma , *ONCOGENIC viruses , *PAPILLOMAVIRUS diseases , *IN situ hybridization , *IMMUNOHISTOCHEMISTRY , *PATIENTS ,ALIMENTARY canal tumors - Abstract
Summary: Objectives: Patients with human papillomavirus (HPV)-related oropharyngeal squamous cell carcinoma (OPSCC) have a reduced risk of developing second primary upper aerodigestive tract (UADT) tumours compared to patients with HPV-negative primary tumours at the same site. To determine whether this finding might be explained by a lack of viral-induced field cancerisation or multifocal infection, we investigated whether there was epithelial dysplasia and/or evidence of HPV infection at other pharyngeal mucosal sites in patients presenting with the disease. Materials and methods: Sixty-three patients with primary tonsil SCC and 108 pharyngeal endoscopic biopsies, representing at least one pharyngeal subsite from each patient, were included in this study. Tissue samples were tested using HPV PCR (GP5+/6+), p16 immunohistochemistry (IHC) and high risk HPV DNA in situ hybridisation (ISH). Results: There were 46 patients with HPV-related SCC and 17 patients with HPV-negative disease. PCR detected HPV DNA in a fifth of pharyngeal endoscopic biopsies and was equally likely to be from a patient with HPV-related SCC as from a patient with HPV negative disease. All PCR positive cases were tested using p16 IHC and high risk HPV ISH and only three biopsies were positive. Significantly, these three biopsies all showed evidence of epithelial dysplasia and were from patients with an HPV positive index tumour. Conclusion: Our data suggest that virus-induced field cancerisation and/or multifocal oncogenic HPV infection of the pharynx is uncommon in OPSCC and supports the concept that these patients have a lower risk of developing second primary tumours of the UADT. [Copyright &y& Elsevier]
- Published
- 2014
- Full Text
- View/download PDF
14. Overview of Oral Potentially Malignant Disorders: From Risk Factors to Specific Therapies.
- Author
-
Lorini, Luigi, Bescós Atín, Coro, Thavaraj, Selvam, Müller-Richter, Urs, Alberola Ferranti, Margarita, Pamias Romero, Jorge, Sáez Barba, Manel, de Pablo García-Cuenca, Alba, Braña García, Irene, Bossi, Paolo, Nuciforo, Paolo, and Simonetti, Sara
- Subjects
MOUTH tumors ,EARLY detection of cancer ,PATIENT-centered care ,SQUAMOUS cell carcinoma ,DISEASE risk factors ,SYMPTOMS - Abstract
Simple Summary: Oral potentially malignant disorders (OPMDs) include a group of oral mucosal diseases with different morphological characteristics that are able to progress to oral squamous cell carcinoma (OSCC). Given OSCC's poor prognosis and high mortality, early diagnosis is a priority step in OSCC. Extrinsic and intrinsic risk factors and etiologies are involved in developing and malignant transformation of oral lesions, and different molecular alterations have been described in early lesions associated with a potential malignant behavior. This review summarizes the information about clinical, morphological and molecular features of OPMDs, with an emphasis on the early detection techniques and an overview of the surgical and systemic therapies' effectiveness. Oral squamous cell carcinoma (OSCC) is a very aggressive cancer, representing one of the most common malignancies worldwide. Oral potentially malignant disorders (OPMDs) regroup a variegate set of different histological lesions, characterized by the potential capacity to transform in OSCC. Most of the risk factors associated with OSCC are present also in OPMDs' development; however, the molecular mechanisms and steps of malignant transformation are still unknown. Treatment of OSCC, including surgery, systemic therapy and radiotherapy (alone or in combination), has suffered a dramatic change in last years, especially with the introduction of immunotherapy. However, most cases are diagnosed during the advanced stage of the disease, decreasing drastically the survival rate of the patients. Hence, early diagnosis of premalignant conditions (OPMDs) is a priority in oral cancer, as well as a massive education about risk factors, the understanding of mechanisms involved in malignant progression and the development of specific and more efficient therapies. The aim of this article is to review epidemiological, clinical, morphological and molecular features of OPMDs, with the purpose to lay the foundation for an exhaustive comprehension of these lesions and their ability of malignant transformation and for the development of more effective and personalized treatments. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
15. Osseointegrated Implants: A Potential Route of Entry for Squamous Cell Carcinoma of the Mandible.
- Author
-
Schache, Andrew, Thavaraj, Selvam, and Kalavrezos, Nicholas
- Subjects
OSSEOINTEGRATED dental implants ,SQUAMOUS cell carcinoma ,MANDIBLE ,CANCER - Abstract
Abstract: Documented cases of oral squamous cell carcinoma in relation to osseointegrated implants are rare. We present the first case with evidence to suggest that implants provide a route of entry for squamous cell carcinoma to the mandible. [Copyright &y& Elsevier]
- Published
- 2008
- Full Text
- View/download PDF
16. TNM 8 staging is a better prognosticator than TNM 7 for patients with locally advanced oral cavity squamous cell carcinoma treated with surgery and post-operative radiotherapy.
- Author
-
Sambasivan, Khrishanthne, Sassoon, Isabel, Thavaraj, Selvam, Kennedy, Robert, Doss, Gowardhanan, Michaelidou, Andriana, Odell, Edward, Sandison, Ann, Hall, Gillian, Morgan, Peter, Collins, Lisette Hannah Claire, Lyons, Andrew, Cascarini, Luke, Fry, Alastair, Oakley, Richard, Simo, Ricard, Jeannon, Jean-Pierre, Petkar, Imran, Reis Ferreira, Miguel, and Kong, Anthony
- Subjects
- *
SQUAMOUS cell carcinoma , *SURGICAL margin , *OVERALL survival , *PROGRESSION-free survival , *DISEASE risk factors , *TUMOR classification , *CHEMORADIOTHERAPY - Abstract
• This is an analysis of stage III-IV oral cancer patients, comparing TNM 8 to TNM 7. • TNM 8 is a better prognosticator for OS, DFS and early disease recurrence. • On MVA, TNM 8 stage, margin status and performance status affect overall survival. • Patients aged < 60 years who smoked less were more likely to recur within 12 months. To assess TNM 8 staging in discriminating overall survival (OS) amongst patients with locally advanced oral cavity squamous cell carcinoma (OCSCC) treated with surgery and post-operative radiotherapy (PORT), compared to TNM 7. Data from OCSCC patients treated with surgery and PORT between January 2010 and December 2018 were reviewed. Demographics, tumour characteristics and treatment response data were collected, and patients staged according to both TNM 7 and TNM 8. OS and disease free survival (DFS) were estimated using the Kaplan Meier method. Univariate and multivariable analyses were conducted for factors affecting OS, DFS and early disease recurrence within 12 months. Overall 172 patients were analyzed. Median follow up was 32 months for all patients and 48 months for surviving patients. TNM 8 staging demonstrated significant stratification of OS and DFS amongst the entire cohort, whereas TNM 7 staging did not. On multivariable analysis, TNM 8 stage, performance status (PS) and a positive surgical margin were prognostic for OS. Looking at disease recurrence within 12 months, TNM 8 stage IVB, presence of lymphovascular invasion (LVSI), younger age and lesser smoking history were predictive factors on multivariable analysis. TNM 8 is a good development of its predecessor in terms of predicting survival for patients with locally advanced OCSCC. We have also identified younger age (<60 years) and a smoking history of <10 pack years as risk factors for early disease recurrence, potentially representing a separate biological cohort within OCSCC patients. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
17. Multifactorial estimation of clinical outcome in HPV-associated oropharyngeal squamous cell carcinoma via automated image analysis of routine diagnostic H&E slides and neural network modelling.
- Author
-
Hue, Jonas, Valinciute, Zaneta, Thavaraj, Selvam, and Veschini, Lorenzo
- Subjects
- *
ARTIFICIAL neural networks , *IMAGE analysis , *SQUAMOUS cell carcinoma , *HUMAN papillomavirus , *MULTIVARIATE analysis - Abstract
• High content image analysis allows single-cell evaluation of HPV + OpSCC H&E slides. • Established and novel prognostic features have been identified. • Neural network model can predict patient outcomes with promising accuracy. • Automated H&E analysis is prognostic without additional diagnostic tests. Routine haematoxylin and eosin (H&E) photomicrographs from human papillomavirus-associated oropharyngeal squamous cell carcinomas (HPV + OpSCC) contain a wealth of prognostic information. In this study, we developed a high content image analysis (HCIA) workflow to quantify features of H&E images from HPV + OpSCC patients to identify prognostic features and predict patient outcomes. First, we have developed an open-source HCIA tool for single-cell segmentation and classification of H&E images. Subsequently, we have used our HCIA tool to analyse a set of 889 images from diagnostic H&E slides in a retrospective cohort of HPV + OpSCC patients with favourable (FO, n = 60) or unfavourable (UO, n = 30) outcomes. We have identified and measured 31 prognostic features which were quantified in each sample and used to train a neural network (NN) model to predict patient outcomes. Univariate and multivariate statistical analyses revealed significant differences between FO and UO patients in 31 and 17 variables, respectively (P < 0.05). At the single-image level, the NN model had an overall accuracy of 72.5% and 71.2% in recognising FO and UO patients when applied to test or validation sets, respectively. When considering 10 images per patient, the accuracy of the NN model increased to 86.7% in the test set. Our open-source H&E analysis workflow and predictive models confirm previously reported prognostic features and identifies novel factors which predict HPV + OpSCC outcomes with promising accuracy. Our work supports the use of machine learning in digital pathology to exploit clinically relevant features in routine diagnostic pathology without additional biomarkers. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
18. Interplay of adherens junctions and matrix proteolysis determines the invasive pattern and growth of squamous cell carcinoma.
- Author
-
Takuya Kato, Jenkins, Robert P., Derzsi, Stefanie, Tozluoglu, Melda, Rullan, Antonio, Hooper, Steven, Chaleil, Raphaël A. G., Joyce, Holly, Xiao Fu, Thavaraj, Selvam, Bates, Paul A., and Sahai, Erik
- Subjects
- *
SQUAMOUS cell carcinoma , *ADHERENS junctions , *CELL junctions , *CELL growth , *LYMPHATIC metastasis - Abstract
Cancers, such as squamous cell carcinoma, frequently invade as multicellular units. However, these invading units can be organised in a variety of ways, ranging from thin discontinuous strands to thick 'pushing' collectives. Here we employ an integrated experimental and computational approach to identify the factors that determine the mode of collective cancer cell invasion. We find that matrix proteolysis is linked to the formation of wide strands but has little effect on the maximum extent of invasion. Cell-cell junctions also favour wide strands, but our analysis also reveals a requirement for cell-cell junctions for efficient invasion in response to uniform directional cues. Unexpectedly, the ability to generate wide invasive strands is coupled to the ability to grow effectively when surrounded by extracellular matrix in three-dimensional assays. Combinatorial perturbation of both matrix proteolysis and cell-cell adhesion demonstrates that the most aggressive cancer behaviour, both in terms of invasion and growth, is achieved at high levels of cell-cell adhesion and high levels of proteolysis. Contrary to expectation, cells with canonical mesenchymal traits - no cell-cell junctions and high proteolysis - exhibit reduced growth and lymph node metastasis. Thus, we conclude that the ability of squamous cell carcinoma cells to invade effectively is also linked to their ability to generate space for proliferation in confined contexts. These data provide an explanation for the apparent advantage of retaining cell-cell junctions in squamous cell carcinomas. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
19. Evaluation of human papillomavirus testing for squamous cell carcinoma of the tonsil in clinical practice.
- Author
-
Thavaraj, Selvam, Stokes, Angela, Guerra, Eliete, Bible, Jon, Halligan, Eugene, Long, Anna, Okpokam, Atuora, Sloan, Philip, Odell, Edward, and Robinson, Max
- Subjects
- *
PAPILLOMAVIRUS diseases , *PAPILLOMAVIRUSES , *SQUAMOUS cell carcinoma , *CANCER prognosis , *GENES , *CLINICAL trials , *POLYMERASE chain reaction - Abstract
Background Oncogenic human papillomavirus (HPV)-associated oropharyngeal squamous cell carcinoma (SCC) is a subtype of head-and-neck cancer with a distinct clinical and prognostic profile. While there are calls to undertake HPV testing for oropharyngeal SCCs within the diagnostic setting and for clinical trials, there are currently no internationally accepted standards. Methods 142 tonsil SCCs were tested using p16 immunohistochemistry (IHC), high-risk HPV DNA in situ hybridisation (ISH) and HPV DNA polymerase chain reaction (PCR; GP5+/6+ primers). Results There were high levels of agreement between pathologists for p16 IHC and HPV ISH scoring; however, around 10% of HPV ISH cases showed some interobserver discrepancy that was resolved by slide review. The combination of p16 IHC and HPV ISH classified 53% of the samples as HPV-positive, whereas the combination of p16 IHC and HPV PCR classified 61% of the samples as HPV-positive. By employing a three-tiered, staged algorithm (p16 IHC/HPV ISH/HPV PCR), the authors were able to classify 98% of the cases as either HPV-positive (p16 IHC+/HPV DNA+; 62%) or HPV-negative (p16 IHC⇔'/HPV DNA⇔'; 35%). Conclusions The current study suggests that using a combination of p16 IHC/HPV ISH/HPV PCR, in a three-tiered, staged algorithm, in conjunction with consensus reporting of HPV ISH, leads to less equivocal molecular classification. In order to ensure consistent reporting of this emerging disease, it is increasingly important for the head-and-neck oncology community to define the minimum requirements for assigning a diagnosis of 'HPV-related⇔(tm) oropharyngeal SCC in order to inform prognosis and for stratification in clinical trials. [ABSTRACT FROM AUTHOR]
- Published
- 2011
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.